Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 38.30
+0.08 (0.21%)
Nov 13, 2026, 3:00 PM CST
Autobio Diagnostics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 602.17 | 592.27 | 465.37 | 1,486 | 1,138 | 769.4 |
Short-Term Investments | - | 2,957 | 3,574 | 2,333 | 3,141 | 3,000 |
Trading Asset Securities | 936.95 | 502.1 | 3.61 | 700.57 | - | 7.34 |
Cash & Short-Term Investments | 1,539 | 4,052 | 4,043 | 4,521 | 4,278 | 3,777 |
Cash Growth | 74.32% | 0.23% | -10.57% | 5.66% | 13.27% | 7.75% |
Accounts Receivable | 1,246 | 1,195 | 1,177 | 1,181 | 1,074 | 1,003 |
Other Receivables | 44.81 | 65.81 | 110.74 | 24.25 | 34.86 | 31.69 |
Receivables | 1,291 | 1,261 | 1,288 | 1,206 | 1,109 | 1,035 |
Inventory | 1,073 | 935.45 | 1,153 | 778.29 | 752.3 | 589.34 |
Other Current Assets | 2,026 | 59.88 | 59.25 | 108.54 | 113.63 | 156.62 |
Total Current Assets | 5,930 | 6,308 | 6,543 | 6,613 | 6,254 | 5,558 |
Property, Plant & Equipment | 3,691 | 3,865 | 3,982 | 3,883 | 3,293 | 2,864 |
Long-Term Investments | 260.49 | 178.63 | 172.54 | 123.31 | 13.76 | 1.72 |
Goodwill | 165.14 | 164.65 | 164.65 | 164.65 | 164.65 | 164.65 |
Other Intangible Assets | 213.79 | 168.14 | 136.09 | 179.03 | 203.27 | 227.85 |
Long-Term Deferred Tax Assets | 389.66 | 349.2 | 335.66 | 274.61 | 238.73 | 201.76 |
Long-Term Deferred Charges | 346.74 | 1,087 | 382.71 | 179.23 | 169.97 | 137.11 |
Other Long-Term Assets | 1,340 | 168.97 | 158.7 | 137.55 | 135.59 | 78.07 |
Total Assets | 12,337 | 12,290 | 11,875 | 11,554 | 10,472 | 9,233 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,469 | 1,522 | 1,135 | 726.15 | 1,010 | 355.24 |
Accrued Expenses | 188.11 | 444.99 | 349.51 | 364.54 | 335.93 | 238.07 |
Short-Term Debt | 21.93 | 38.34 | 240.21 | 353.28 | 113.84 | 121.39 |
Current Portion of Long-Term Debt | - | - | 285 | 342 | - | 100.08 |
Current Portion of Leases | - | 6.26 | 8.34 | 10.93 | 12.56 | 9.78 |
Current Income Taxes Payable | 137.91 | 127.28 | 102.38 | 137.85 | 86.48 | 77.62 |
Current Unearned Revenue | 124.37 | 175.53 | 166.11 | 148.14 | 135.48 | 125.1 |
Other Current Liabilities | 479.39 | 315.12 | 372.71 | 400.25 | 472.27 | 431.28 |
Total Current Liabilities | 2,421 | 2,629 | 2,660 | 2,483 | 2,167 | 1,459 |
Long-Term Leases | 10.81 | 10.28 | 20.63 | 24.64 | 16.26 | 26.16 |
Long-Term Unearned Revenue | 545.45 | 379.83 | 214.65 | 118.98 | 101.77 | 75.68 |
Long-Term Deferred Tax Liabilities | 226.33 | 246.73 | 284.19 | 258.03 | 273.03 | 269.1 |
Other Long-Term Liabilities | 8.91 | 7.34 | 4.25 | 2.92 | 2.22 | - |
Total Liabilities | 3,213 | 3,273 | 3,183 | 2,888 | 2,560 | 1,829 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 571.42 | 571.42 | 581.01 | 586.27 | 586.27 | 586.27 |
Additional Paid-In Capital | - | 3,329 | 3,819 | 4,101 | 4,101 | 4,101 |
Retained Earnings | 5,123 | 5,024 | 4,676 | 4,091 | 3,338 | 2,590 |
Treasury Stock | - | - | -461.03 | -243.3 | -243.3 | - |
Comprehensive Income & Other | 3,329 | 0.94 | 1.14 | 1.03 | 0.61 | -0.07 |
Total Common Equity | 9,024 | 8,926 | 8,617 | 8,535 | 7,783 | 7,277 |
Minority Interest | 100.47 | 90.09 | 75.27 | 130.87 | 129.59 | 126.49 |
Shareholders' Equity | 9,124 | 9,016 | 8,692 | 8,666 | 7,912 | 7,403 |
Total Liabilities & Equity | 12,337 | 12,290 | 11,875 | 11,554 | 10,472 | 9,233 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 32.73 | 54.88 | 554.19 | 730.85 | 142.66 | 257.4 |
Net Cash (Debt) | 1,506 | 3,997 | 3,488 | 3,790 | 4,136 | 3,520 |
Net Cash Growth | 85.15% | 14.58% | -7.95% | -8.37% | 17.50% | 6.70% |
Net Cash Per Share | 2.64 | 7.00 | 6.05 | 6.54 | 7.08 | 6.00 |
Filing Date Shares Outstanding | 571.42 | 571.42 | 576.91 | 581.01 | 581.01 | 586.27 |
Total Common Shares Outstanding | 571.42 | 571.42 | 576.91 | 581.01 | 581.01 | 586.27 |
Working Capital | 3,508 | 3,679 | 3,883 | 4,130 | 4,087 | 4,099 |
Book Value Per Share | 15.79 | 15.62 | 14.94 | 14.69 | 13.39 | 12.41 |
Tangible Book Value | 8,645 | 8,593 | 8,316 | 8,192 | 7,415 | 6,884 |
Tangible Book Value Per Share | 15.13 | 15.04 | 14.41 | 14.10 | 12.76 | 11.74 |
Buildings | - | 3,004 | 1,895 | 1,152 | 829.25 | 473.02 |
Machinery | - | 2,845 | 2,916 | 2,740 | 2,492 | 2,283 |
Construction In Progress | - | 61.75 | 987.28 | 1,591 | 1,272 | 1,105 |